We are thrilled to announce Dr. Eliot Peyster, MD, MSc, from the University of Pennsylvania, as a recipient of the 2024 FSR Cardiac Sarcoidosis Grant 🔗 Learn more about FSR’s commitment to research: https://t.co/qGsEF0nttm

Advancing Awareness at AHA Scientific Sessions in Chicago! 🎉 📸: Dr. Selvaraj, our 2023 cardiac grantee, whose work is making a significant impact in the field of sarcoidosis research! Together, we’re working to improve outcomes for those affected by sarcoidosis.

Measurement of point-of-care beta-hydroxybutyrate levels prior to FDG-PET is feasible and may facilitate the management of patients referred for myocardial inflammation @mkvidula @pacoebravo @PennCardiology @PennMedicine #AHAJournals @JiwonKimMD https://t.co/ksl4ZIpqUA

Love to see this, but the right answer should have been repeat the scan with longer ketosis, we're finally getting there

Reminds me of cards fellows looking at SPECT https://t.co/Vn5HxZ9PQU

Stress perfusion battle royale! Through head to head comparison of stress perfusion #CMR vs 82Rb #cvPET after #YesCCT, both approaches had moderate sensitivities & high specificities to discriminate obstructive #cvCAD by #FFR. https://t.co/VfYboaIB29 #JACCIMG @lostrasmussen

Multicenter #JACCIMG #whyCMR study of #COVID19 pts w/ suspicion for cardiac involvement: nonischemic & ischemic patterns = frequent if cardiac symptoms, abnormal #ECG, or elevated cardiac biomarker elevation present. https://t.co/yYl8uBz6ps #CardioTwitter @mkvidula

A new @PennCardiology #clinicalcase aimed to: 👉formulate diagnoses of persistent FDG uptake on serial PET imaging 👉understand the mechanistic rationale of alt. causes that may result in persistent FDG uptake https://t.co/ZJ8UQxe534 #Aneurysm #CVImaging @mkvidula @pacoebravo

Not always more is better, this study confirms that. Just image the chest in this population.

If you adjust for LGE, FDG is no longer predictive of adverse events in patients with suspected inflammatory cardiomyopathy (it seems)

Myocardial injury in patients with #COVID19 & suspected cardiac involvement is not well understood. This 📄 by @mkvidula et al. aimed to characterize myocardial injury in these patients referred for #CMR. 👉 https://t.co/GReZwd1a3f #CardioTwitter

Don't miss another Radiology Grand Round Session next week, on Tuesday, February 14 @ 12-1 PM! In person and live-streaming available. Stay tuned for more details. #radiology #grandrounds

The Myocarditis Foundation is Pleased to Announce the Recipient of the Foundation’s 2022 Fellowship Grant Award. Read about Dr. KC’s research here

A new @pennmedicine study investigated the effect of immunosuppressive 🩺 therapy & biopsy 💉 status to achieve CTR, PTR or NR on myocardial FDG-PET/CT. Learn more➡️ https://t.co/H5RollrTyg @senthil_selv @mkvidula @leegoldbergmd8 @pacoebravo

Through #cvNuc FDG-PET, a favorable response was more common when using moderate-to-high intensity steroids. After nearly 5 years, biopsy-proven and with preserved systolic function were less likely to experience adverse outcomes. https://t.co/b3AZsOdPTe #JACCIMG #Sarcoidosis

Led by @mkvidula, our metabolomics analysis of myocardial glucose uptake on PET during ketosis 🔑 role for C4-OH Simpub @AHAMeetings #AHA2022 & @JACCJournals #JACCBTS 🙏@pacoebravo @SvatiShah @MarguliesLab @AranyLab @tcappola1 @dankellymd @DukeHeartCenter https://t.co/lAcIJXaQnB

It’s about time

Only days left to submit abstracts for our February '22 Latin America & The Caribbean #GHICC with @CHOPRadiology and @UPennCGH! Info and submission guidelines: https://t.co/eZItZ3VxII @farouk_dako @oterocobo #globalhealth #RadTwitter #RadEd #radiodiagnostico #radiología

Mental stress-induced myocardial ischemia appears to carry a stronger risk than conventional stress–induced ischemia for CV death, nonfatal myocardial infarction, or heart failure hospitalization. https://t.co/zq6X0pwGPf #cardiology @kewatson

More and more evidence of the important prognostic value of CFR independent of the condition